Jen-Yin Hou

5PUBLICATIONS
24CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 18, 2026
Prognostic Impact of Sequential Measurable Residual Disease and KIT Variant Status in Pediatric Core-Binding Factor Acute Myeloid Leukemia: A Retrospective Multicenter Study of the Taiwan Pediatric Oncology Group.

|Apr 13, 2023
Pediatric Extracranial Germ Cell Tumors: Review of Clinics and Perspectives in Application of Autologous Stem Cell Transplantation.

Chong-Zhi Lew, Hsi-Che Liu, Jen-Yin Hou

|Apr 13, 2023
Application of Drug Testing Platforms in Circulating Tumor Cells and Validation of a Patient-Derived Xenograft Mouse Model in Patient with Primary Intracranial Ependymomas with Extraneural Metastases.

Muh-Lii Liang, Ting-Chi Yeh, Man-Hsu Huang

|Feb 01, 2021
RAS pathway mutation is an added-value biomarker in pediatric Philadelphia-negative B-cell acute lymphoblastic leukemia with IKZF1 deletions.

Ying-Jung Huang, Hsi-Che Liu, Tang-Her Jaing

|Jul 17, 2019
Efficacy and safety of denosumab therapy for low bone mineral density in childhood cancer survivors: A report of preliminary experience.

Ting-Huan Huang, Hsi-Che Liu, Jen-Yin Hou

Pageof 1

Frequent Collaborators

5 joint publications

Ting-Chi Yeh

2 joint publications

Ting-Huan Huang

2 joint publications

Tang-Her Jaing

2 joint publications

Shih-Hsiang Chen